Datadog Surges in Market Debut
Datadog (Nasdaq: DDOG) shares popped in its market debut with the cloud company extending gains after its IPO. Datadog raised almost $650 million in its IPO with a market valuation of $10.88 billion.
SmileDirectClub Brushes Away Debut Slump
The direct-to-consumer teeth-straightening startup turned its frown upside down following a disappointing market debut.
IPO Watch - Autumn Preview
The U.S. market is gearing up for its biggest IPO year measured by proceeds since 2014. SmileDirectClub, Peloton Interactive, 10x Genomics, IGM Biosciences and Satsuma Pharmaceuticals will list on the NASDAQ.
Peloton Pedals Closer to IPO
Peloton Interactive filed for an IPO with initial valuation estimates pegging a hefty multi-billion dollar sum. The company has experienced massive growth accompanied by significant losses. The stock for the fitness startup will be listed on the Nasdaq under the symbol PTON.
IPO Market Awaits Autumn Debuts
InMode Ltd. (NASDAQ: INMD) debuted after pricing at the lower end of its range and traded right below its IPO price. Venture-backed IPOs are on tap with WeWork and Cloudflare preparing to go public in the autumn.
Kura Sushi Spears IPO Catch
Kura Sushi USA (NASDAQ: KRUS) soared 40% from the its IPO price. The restaurant chain operates 22 restaurants in the country and plans to double the number of outlets by fiscal 2023.
China's Wanda Sports Downsizes IPO
Wanda Sports Group (NASDAQ: WSG) downsized its US IPO as the firm behind the Ironman triathlon plans to use the proceeds to repay debt and fund strategic investments. Two digital health companies debuted on the NASDAQ after a three-year pause in the sector.
Afya Spikes in NASDAQ IPO
Afya celebrated its IPO on the Nasdaq and soared over 20% on its first day of trade. The Brazilian company plans to use the proceeds to integrate more products and new schools into its growing medical education network. Fulcrum Therapeutics and Mirum Pharmaceuticals also marked their debut on the NASDAQ.
BridgeBio Pharma and Adaptive Biotech Soar...
Several biotech names debuted on the NASDAQ and soared as trading kicked off. Shares of BridgeBio Pharma (NASDAQ: BBIO) railed with the company garnering the title of top biotech IPO of 2019.
Grocery Outlet Pops and Retreats
Grocery Outlet (NASDAQ: GO) shares advanced as the discount grocer marked its debut after raising $378 million. Several biotechs also launched with mixed results as they went public.
Fiverr to High-Five Public Market?
The online gig economy marketplace has filed its IPO prospectus and plans to list under FVRR on the NYSE. Fiverr filed updated plans for a $100 million IPO of its common stock.
CrowdStrike Sets IPO Price
CrowdStrike may soon take the title of tech unicorn with the biggest U.S. IPO for a VC-backed cybersecurity company.
Diamondback's Rattler: Biggest Energy...
Rattler Midstream LP (NASDAQ: RTLR), a subsidiary of Diamondback Energy Inc., began trading with a better-than-expected public offering. Biotech IPOs were mixed as Peloton Therapeutics, Bicycle Therapeutics and Ideaya Biosciences went public.
Fastly Leaps in Market Debut
Fastly, Inc. (NYSE: FSLY) raised $180 million in its IPO and advanced 50% in its first day as a public company. Company CFO, Adriel Lares, discussed plans for the IPO proceeds and how Fastly will scale its business.
Uber IPO Marks Rocky Debut
Uber Technologies (NYSE: UBER) priced its IPO at $45 a share but shares hit reverse in the highly-anticipated listing. The gig economy startup lowered its valuation expectations and went public against a backdrop of a market selloff.
Slack Opts For Direct Listing
Slack is sidestepping the traditional IPO process. The workplace messaging start-up disclosed business details in its S-1 filing for its direct listing on the NYSE.
Pinterest Spikes In Wall Street Debut
Pinterest (NYSE: PINS) priced at $19 a share for its IPO. PINS rallied on its first day of trade valuing the company at over $12 billion. The social platform for bookmarking images has 250 million MAUs.
Tufin Spikes In Debut As It Transforms...
Tufin Software Technologies Ltd. (NYSE: TFN) shares rallied in its market debut after pricing at the high end of its range at $14 a share. The cybersecurity firm's CEO Ruvi Kitov, zooms in on security policy as he chronicles pioneering a policy-centric approach to IT operations.